Overview

A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)

Status:
COMPLETED
Trial end date:
2024-01-19
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of Genakumab in prevention of acute flares in gout patients initiating urate-lowering therapyurate-lowering
Phase:
PHASE2
Details
Lead Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.
Collaborator:
Huashan Hospital
Treatments:
Colchicine
Injections